Navigation Links
Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market

Oridion Signs New Distributor Agreement With IMI Expanding its Presence in... -- JERUSALEM and NEEDHAM, Massachusetts, August 18, 2010 /PRNewswire-FirstCall/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Contracts Click to view news release full screen  

Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market


JERUSALEM and NEEDHAM, Massachusetts, August 18, 2010 /PRNewswire-FirstCall/ -- Oridion (SIX Swiss Exchange: ORIDN), creator of the Smart Capnography(TM) family of algorithm-based solutions (Integrated Pulmonary Index(TM), SARA(TM), and Smart Breath Detection Algorithm(TM)), announced the signing of a new agreement with IMI Co. Ltd., a leading distributor of medical equipment in Japan. This agreement provides Oridion with the opportunity to further expand into the Japanese market with its line of Microstream(R) capnography monitoring products.

IMI will bundle sales of Capnostream(R)20 Smart Capnography monitors including IPI* with their ventilators. This powerful combination will be offered as SafetySet(TM), an innovative solution to improve patient safety and make a clinical difference in patient care. IMI will begin selling the Capnostream(R)20 monitors and patented FilterLine(R) etCO2 sampling products immediately into the Critical Care environment and Home Care areas throughout Japan.

Mr. Kazumasa Tsumuga, President of IMI, said: "We are happy to join with Oridion to make available the best capnography technology to our hospital markets in Japan. We believe the collaboration between IMI and Oridion will help improve the safety for all the patient populations in all clinical settings in Japan."

Gerry Feldman, President of Oridion Capnography Inc., remarks, "We are honored to be working with IMI. The SafetySet package combining Capnostream capnography with ventilators sold by IMI is a pioneering strategy that will provide added safety for patients in hospitals throughout Japan. Oridion is committed to improving the standard of healthcare worldwide and will continue to offer new ways to improve patient safety and make a clinical difference in patient care."

*IPI helps caregivers manage complicated monitoring parameters with a single, simple number. The IPI utilizes real time measures and interactions of four parameters - exhaled carbon dioxide (etCO2), respiration rate, pulse rate, and oxygenation (SpO2) - to provide a single indexed value, enabling clinicians to instantly assess the patient's respiratory status.

SARA (Smart Alarm Respiratory Analysis) is an alarm management algorithm that, together with the Smart Breath Detection Algorithm, recognizes and reduces clinically insignificant alarms while accurately reflecting the patient's condition and preserving caregiver alarm vigilance.

About Oridion

Oridion Systems Ltd. ( is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States and Israel.

Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream(R) technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.

Certain statements made herein that are not historical are forward-looking. The words "estimate" "project" "intend" "expect" "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, our ability to maintain profits, the market demands for our Capnography products, our ability to focus our team on the Capnography business, changes in general economic and business conditions, inability to maintain market acceptance to the Company's products, inability to timely develop and introduce new technologies, products and applications, rapid changes in the market for the Company's products, loss of market share and pressure on prices resulting from competition, introduction of competing products by other companies, inability to manage growth and expansion, loss of key OEM partners, inability to attract and retain qualified personnel, inability to protect the Company's proprietary technology. The Company does not assure any obligation to update the forward-looking information contained in this press release.

For further Oridion information please contact: Alan Adler, Chairman and Chief Executive Officer Walter Tabachnik, Chief Financial Officer Elena Gerberg, Investor Relations e-mail: website: phone: +972-2-589-9159 address: Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel

SOURCE Oridion Systems Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
2. Oridion Signs Agreement With Major US Health Plan Provider for Microstream(R) Capnography
3. Oridion Announces Significant Medical Research to be Presented at AARC Congress
4. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
5. BioNeutral Signs Agreement With a Non-profit for Long-Term Removal of Formaldehyde to Save 10,000 Mobile Homes in Louisiana
6. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
7. Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
8. Martek Signs Multi-Year Sole-Source Supply Agreement With Hero
9. NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules
10. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
11. Huifeng Bio-Pharmaceutical (HFGB) Signs Exclusive Management Operating Agreement with Xian Qinba Xintong Medical Ltd.; HFGB to Retain Up to 70% of Qinbas Total Profit
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  ATCC, the premier global ... it has been selected by The Michael J. Fox ... lines to academic, pharmaceutical, and biotechnology organizations committed to ... the United States , and more than ... the United States , and more than ...
(Date:10/8/2015)... Global Biologics and Biosimilars ... Biosimilars industry . --> Big Market ... Industry 2015 Deep Market Research Report, Size, Share, ... and depth research report on Global Biologics ... , --> ) , ...
(Date:10/8/2015)... 8, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) ... on the development of autologous cell therapies, today announced its ... taking place in the month of October: ... RepliCel will be presenting at the annual Partnering ... Mesa to be held October 7-9 in ...
(Date:10/8/2015)... ... October 08, 2015 , ... ProMIS Neurosciences, ... agreement to develop and commercialize intellectual property rights belonging to The University of ... 2009, and affords exclusive worldwide rights to intellectual property based on use of ...
Breaking Biology Technology:
... , Purpose , ... the use of chloramphenicol (CAP) as a veterinary drug for food ... for the identification and quantification of CAP in milk and milk ... many analytical procedures are described in the literature, the presented method ...
... , ... and detailed structural data of highlyknotted spider toxins , ... The primary structure determination ... cLC 492 sequencing system and the QSTAR Pulsar hybrid quadrupole time-of-flight mass spectrometer. ...
... Abstract , The generation of hybrid ... production is a fundamental and well-established technique. However, , ... , has varied little over the years. ... antigens is particularly problematic. We have developed a robust , ...
Cached Biology Technology:
(Date:10/2/2015)... DUBLIN , Oct. 02 2015 ... addition of the "Enforcing the Law Using ... ) has announced the addition of ... report to their offering. --> Research ... addition of the "Enforcing the Law Using ...
(Date:9/30/2015)... GARDENS, Fla. , Sept. 30, 2015  The ... this month issued another key ruling in favor of ... determination that Korean fingerprint scanner company Suprema and its ... Act of 1930, a trade provision that declares it ... import trade, by infringing two of Crossmatch,s patents, the ...
(Date:9/29/2015)... MILWAUKEE , Sept. 29, 2015  iDAvatars is excited ... partners to introduce its product to market. The official announcement was ... Cognitive Economy event in San Francisco ... Avatar platform powered by IBM Watson. "It is ... the first 100 companies to bring to market the cognitive ...
Breaking Biology News(10 mins):
... 16 issue of the journal Cell Host & ... this immune response in mice infected with lymphocytic choriomeningitis ... of drug treatments for immunosuppressive diseases in humans. ... of the interferon response in vivo," says the paper,s ...
... at the University of Delaware have discovered that when the ... it can send out an S.O.S. to the roots for ... that brings beneficial bacteria to the rescue. The finding ... of passing pathogens--and sheds new light on a sophisticated signaling ...
... TALLAHASSEE, Fla. -- The discovery of a protein involved ... a researcher at the Florida State University College of ... Institutes of Health. Branko Stefanovic, associate professor in ... Medicine, hopes his discovery could lead to treatment methods ...
Cached Biology News: